PyL in Patients With High Risk and Biochemically Recurrent Prostate Cancer
Part of paid clinical trials in Irvine, California.
- Sponsor
- Hoag Memorial Hospital Presbyterian
- Study ID
- NCT04700332
- Phase
- PHASE2
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- MALE
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- DCFPyL PET/CT — DRUGProstate Membrane Specific Antigen-specific imaging
Study Details
The standard of care imaging of prostate cancer metastases recommended by the National Comprehensive Cancer Network (NCCN), CT of the chest/abdomen/pelvis and bone scan, may be suboptimal. PyL is a novel PET tracer designed to detect prostate specific membrane antigen (PSMA) expressed on prostate cancer cells. PyL PET/CT may provide improved evaluation of clinically significant metastases in patients with prostate cancer.
Key Dates
- Start date
- Feb 1, 2021
- Status verified
- Jul 2021
- Primary completion
- Jul 15, 2022
- Completion
- Dec 15, 2022
Study Design
- Enrollment
- 184 participants (estimated)
- Allocation
- NON_RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- DIAGNOSTIC
Arms
- Experimental: High risk prostate cancerDCFPyL PET/CT will be compared to CT/bone scan for detection of unsuspected metastases in patients with high risk prostate cancer and planned prostatectomy or or radiation therapy
- Experimental: Biochemically recurrent prostate cancerDCFPyL PET/CT will be utilized for detection of unsuspected metastases in patients with biochemically recurrent prostate cancer, but with no evidence of disease on CT/bone scan.
Primary Outcome Measure
Detection of unsuspected metastases in high risk prostate cancer [ Time Frame: up to 4 weeks ]
Central Contacts
- Beth Thomsen949-764-4577
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Hoag Memorial Hospital Presbyterian | Irvine | California | 92618 | Beth Thomsen Gary Ulaner, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Irvine, CA
By condition
By specialty
By research site
Related Studies
- Active Surveillance for Cancer of the Prostate (ASCaP)Recruiting · Jonsson Comprehensive Cancer Center · Los Angeles, California
- SBRT Boost for Unfavorable Prostate Cancer'Recruiting · MemorialCare Health System · Fountain Valley, California
- Pilot Study of (MR) Imaging With Pyruvate (13C) to Detect High Grade Prostate CancerEARLY_PHASE1 · Recruiting · Ivan de Kouchkovsky, MD · San Francisco, California
- A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical StudyPHASE2 · Recruiting · Astellas Pharma Global Development, Inc. · Anchorage, Alaska